Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis☆☆☆
- 1 November 1999
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 104 (5) , 927-933
- https://doi.org/10.1016/s0091-6749(99)70070-9
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: